Biblio

Journal Article
Kawano H, Ito Y, Kanai F, Nakamura E, Tada N, Takai S, Horie S, Kobayashi T, Hino O. Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway. Oncol Rep. 2015.
Liu C-H, Chou C-T, Chen C-H, Chen C-H, Yang S-Y, Ko Y-A, Wu Y-T, Wang C-C, Liu F-C, Yue C-T, et al. Aberrant distribution and function of plasmacytoid dendritic cells in patients with ankylosing spondylitis are associated with unfolded protein response. Kaohsiung J Med Sci. 2020.
Sriraksa R, Zeller C, Dai W, Siddiq A, Walley AJ, Limpaiboon T, Brown R. Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumours. Cancer Prev Res (Phila). 2013.
Sakaguchi H, Muramatsu H, Okuno Y, Makishima H, Xu Y, Furukawa-Hibi Y, Wang X, Narita A, Yoshida K, Shiraishi Y, et al. Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia. PLoS One. 2015;10(12):e0145394.
Tesarova L, Simara P, Stejskal S, Koutna I. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture. PLoS One. 2016;11(6):e0157974.
Planello AC, Ji J, Sharma V, Singhania R, Mbabaali F, Müller F, Alfaro JA, Bock C, De Carvalho DD, Batada NN. Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors. Cell Regen (Lond). 2014;3(1):4.
Xiong L, Wu F, Wu Q, Xu L, Cheung OK, Kang W, Mok MT, Szeto LLM, Lun C-Y, Lung RW, et al. Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming. Nat Commun. 2019;10(1):335.
Davis H, Irshad S, Bansal M, Rafferty H, Boitsova T, Bardella C, Jaeger E, Lewis A, Freeman-Mills L, Giner FC, et al. Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche. Nat Med. 2014.
Forget A, Martignetti L, Puget S, Calzone L, Brabetz S, Picard D, Montagud A, Liva S, Sta A, Dingli F, et al. Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling. Cancer Cell. 2018;34(3):379-395.e7.
Raeisossadati R, Abbaszadegan MReza, Moghbeli M, Tavassoli A, Kihara AHiroaki, Forghanifard MMahdi. Aberrant expression of DPPA2 and HIWI genes in colorectal cancer and their impacts on poor prognosis. Tumour Biol. 2014.
Indu S, Sekhar SC, Sengottaiyan J, Kumar A, Pillai SM, Laloraya M, Kumar PG. Aberrant expression of Dynein light chain 1 is associated with human male factor infertility. Mol Cell Proteomics. 2015.
Ponandai-Srinivasan S, Andersson KL, Nistér M, Saare M, Hassan HA, Varghese SJ, Peters M, Salumets A, Gemzell-Danielsson K, Lalitkumar PGrace Luth. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis. Hum Reprod. 2018.
Hua M, Li J, Wang C, Shao L, Hou M, Peng J, Feng Q. Aberrant expression of microRNA in CD4 cells contributes to Th17/Treg imbalance in primary immune thrombocytopenia. Thromb Res. 2019;177:70-78.
Qiao J, Liu Y, Wu Y, Li X, Zhu F, Xia Y, Yao H, Chu P, Li H, Ma P, et al. Aberrant expression of RUNX3 in patients with immune thrombocytopenia. Int Immunopharmacol. 2015.
Sakao-Suzuki M, Kawasaki H, Akamatsu T, Meguro S, Miyajima H, Iwashita T, Tsutsui Y, Inoue N, Kosugi I. Aberrant fetal macrophage/microglial reactions to cytomegalovirus infection. Ann Clin Transl Neurol. 2014;1(8):570-88.
Paduch DA, Hilz S, Grimson A, Schlegel PN, Jedlicka AE, Wright WW. Aberrant gene expression by Sertoli cells in infertile men with Sertoli cell-only syndrome. PLoS One. 2019;14(5):e0216586.
Massolt ET, Effraimidis G, Korevaar TIM, Wiersinga WM, W Visser E, Peeters RP, Drexhage HA. Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease. PLoS One. 2016;11(4):e0153892.
Visweswaran M, Arfuso F, Warrier S, Dharmarajan A. Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells: Concise review. Stem Cells. 2019.
Wu JK, Kitajewski C, Reiley M, Keung CH, Monteagudo J, Andrews JP, Liou P, Thirumoorthi A, Wong A, Kandel JJ, et al. Aberrant Lymphatic Endothelial Progenitors in Lymphatic Malformation Development. PLoS One. 2015;10(2):e0117352.
Blanco S, Dietmann S, Flores JV, Hussain S, Kutter C, Humphreys P, Lukk M, Lombard P, Treps L, Popis M, et al. Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders. EMBO J. 2014.
Ngalame NNO, Tokar EJ, Person RJ, Xu Y, Waalkes MP. Aberrant microRNA Expression Likely Controls RAS Oncogene Activation During Malignant Transformation of Human Prostate Epithelial and Stem Cells by Arsenic. Toxicol Sci. 2014.
Liang G, Li G, Wang Y, Lei W, Xiao Z. Aberrant miRNA expression response to UV irradiation in human liver cancer cells. Mol Med Rep. 2014.
Abraham AB, Bronstein R, Reddy AS, Maletic-Savatic M, Aguirre A, Tsirka SE. Aberrant Neural Stem Cell Proliferation and Increased Adult Neurogenesis in Mice Lacking Chromatin Protein HMGB2. PLoS One. 2013;8(12):e84838.
Kini AT, Thangaraj KR, Simon E, Shivappagowdar A, Thiagarajan D, Abbas S, Ramachandran A, Venkatraman A. Aberrant Niche Signaling in the Etiopathogenesis of Ulcerative Colitis. Inflamm Bowel Dis. 2015.
Yu J-B, Jiang H, Zhan R-Y. Aberrant Notch signaling in glioblastoma stem cells contributes to tumor recurrence and invasion. Mol Med Rep. 2016.

Pages